Universal Health International Group Holding (HKSE:02211) Interest Expense : HK$-1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Universal Health International Group Holding Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Universal Health International Group Holding's interest expense for the six months ended in Dec. 2023 was HK$ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Universal Health International Group Holding's Operating Income for the six months ended in Dec. 2023 was HK$ -26 Mil. Universal Health International Group Holding's Interest Expense for the six months ended in Dec. 2023 was HK$ -1 Mil. Universal Health International Group Holding did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universal Health International Group Holding Interest Expense Historical Data

The historical data trend for Universal Health International Group Holding's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Health International Group Holding Interest Expense Chart

Universal Health International Group Holding Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-0.34

-2.21

-1.29

-1.38

-1.39

Universal Health International Group Holding Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.20	-1.19	-0.73	-0.68	-0.68

Universal Health International Group Holding Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1 Mil.

Universal Health International Group Holding (HKSE:02211) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universal Health International Group Holding's Interest Expense for the six months ended in Dec. 2023 was HK$-1 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$-26 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$0 Mil.

Universal Health International Group Holding's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Universal Health International Group Holding did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Universal Health International Group Holding (HKSE:02211) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Universal Health International Group Holding Ltd (HKSE:02211) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 14-1, Bei Yi Zhong Road, Tiexi District, Liaoning Province, Shenyang, CHN

Website

http://www.uhighl.com

Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. It sells prescription and OTC products, healthcare products, medical devices, and other personal and family care products. The company operates its business through two segments: Distributions and Retails, out of which, majority of revenue is earned by Distributions Segment.

Executives

Chu Chuanfu	2201 Interest of corporation controlled by you
Jin Dongtao	2201 Interest of corporation controlled by you
Asia Health Century International Inc.
Chen Xiaoyan
Global Health Century International Group Ltd.
Lee Funglun

Universal Health International Group Holding (HKSE:02211) Headlines

No Headlines